Prevalence of SENV-H viraemia among healthy subjects and individuals at risk for parenterally transmitted diseases in Germany

Journal of Viral Hepatitis

Volumn 9, Issue 6, 2002, Pages 455-459

  Schroter M ^a   Laufs, R ^a   Zollner B ^a   Knodler B ^b   Schafer P ^a   Sterneck, M ^a   Fischer, L ^a   Feucht, H H ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b Abteilung fur Transfusionsmedizin   (Germany)

Author keywords

Epidemiology; Polymerase chain reaction; Post transfusion hepatitis; SEN virus

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; SEN VIRUS; SEROLOGY; VIREMIA; VIRUS TRANSMISSION;

EID: 0036436711     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.2002.00390.x     Document Type: Article

References (15)

1. Alter MJ, Margolis HS, Krawczynski K et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992; 327: 1899-1905.
2. Feucht HH, Zöllner B, Polywka S et al. Prevalence of hepatitis G viremia among healthy subjects, individuals with liver disease, and persons at risk for parenteral transmission. J Clin Microbiol 1997; 35: 767-768.
3. Schröter M, Feucht HH, Zöllner B et al. Prevalence of TTV viremia among healthy subjects and individuals at risk for parenterally transmitted diseases in Germany. Hepatol Res 1999; 13: 205-211.
4. Primi D, Fiordalisi G, Mantero GL et al. Identification of SENV genotypes. International patent number WO0028039 (international application published under the patent cooperation treaty) 2001. Internet address: http://ep.espacenet.com/ .
5. Tanaka Y, Primi D, Wang RYH et al. Genomic and molecular evolutionary analysis of a newly identified infectious agent (SEN virus) and its relationship to the TT virus family. J Infect Dis 2001; 183: 359-367.
6. Umemura T, Yeo AET, Sottini A et al. SEN virus infection and its relationship to transfusion-associated hepatitis. Hepatology 2001; 33: 1303-1311.
7. Kumar S, Tamura K, Jakobsen IB, Nei M. MEGA 2: Molecular evolutionary genetics analysis software. Bioinformatics 2001; 17: 1244-1245.
8. Okamoto H, Nishizawa T, Kato N et al. Molecular cloning and characterization of a novel DNA virus (TTV) associated with posttransfusion hepatitis of unknown etiology. Hepatol Res 1998; 10: 1-16.
9. Feucht HH, Zöllner B, Polywka S et al. Distribution of hepatitis G viremia and antibody response to recombinant proteins with special regard to risk factors in 709 patients. Hepatology 1997; 26: 491-494.
10. Okamoto H, Akahane Y, Ukita M et al. Fecal excretion of a nonenveloped DNA virus (TTV) associated with posttransfusion non A-G hepatitis. J Med Virol 1998; 56: 128-132.
11. Wilson LE, Umemura T, Astemborski J et al. Dynamics of SEN virus infection among injection drug users. J Infect Dis 2001; 184: 1315-1319.
12. Tillmann HL, Heiken H, Knapik-Botor A et al. Infection with GB virus C and reduced mortality among HIV-infected patients. N Engl J Med 2001; 345: 761-762.
13. Irving WL, Ball JK, Berridge S et al. TT virus infection in patients with hepatitis C: Frequency, persistence, and sequence heterogeneity. J Infect Dis 1999; 180: 27-34.
14. Itoh K, Takahashi M, Ukita M, Nishizawa T, Okamoto H. Influence of primers on the detection of TT Virus DNA by polymerase chain reaction. J Infect Dis 1999; 180: 1750-1751.
15. Simmonds P, Prescott LE, Logue C, Davidson F, Thomas AE, Ludlam CA. TT virus - Part of the normal human flora? J Infect Dis 1999; 180: 1748-1749.